00000000nam 2200000zi 4500
0019.954444
003CaOODSP
00520250825141002
006m     o  d f      
007cr |n|||||||||
008250825t20192019onc     o    f000 0 eng d
020 |z9780660245416
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aNR16-197/2019E-PDF|zNR16-197/2018E-PDF
24500|aCHO expression platform : |blicensing opportunity L-11266, 11992, 12273, 12671.
264 1|a[Ottawa] : |bNational Research Council Canada = Conseil national de recherches Canada, |c[2019]
264 4|c©2019
300 |a1 online resource (1 page)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCaption title.
500 |aIssued also in French under title: Plateforme d’expression CHO : possibilité d’octroi de licences L-11266, 11992, 12273, 12671.
500 |aThe catalogue number (NR16-197/2018E-PDF) and ISBN (978-0-660-24541-6) assigned to an earlier edition have been copied in this electronic publication.
650 0|aRecombinant proteins.
650 0|aImmunotechnology.
7102 |aNational Research Council Canada, |eissuing body.
77508|tPlateforme d’expression CHO : |w(CaOODSP)9.954445
795 |tCHO expression platform (L-11266 / 11992 / 12273 / 12671) |w(CaOODSP)9.850055
85640|qPDF|s130 KB|uhttps://publications.gc.ca/collections/collection_2025/cnrc-nrc/NR16-197-2019-eng.pdf
8564 |qHTML|sN/A|uhttps://nrc.canada.ca/en/research-development/intellectual-property-licensing/cho-expression-platform-l-11266-11992-12273-12671
986 |a052021